UBE2O remodels the proteome during terminal erythroid differentiation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28774900.
- Also identified by DOI 10.1126/science.aan0218 and PMC identifier 5812729.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
During terminal differentiation, the global protein complement is remodeled, as epitomized by erythrocytes, whose cytosol is ~98% globin. The erythroid proteome undergoes a rapid transition at the reticulocyte stage; however, the mechanisms driving programmed elimination of preexisting cytosolic proteins are unclear. We found that a mutation in the murine <i>Ube2o</i> gene, which encodes a ubiquitin-conjugating enzyme induced during erythropoiesis, results in anemia. Proteomic analysis suggested that UBE2O is a broad-spectrum ubiquitinating enzyme that remodels the erythroid proteome. In particular, ribosome elimination, a hallmark of reticulocyte differentiation, was defective in <i>Ube2o<sup>-/-</sup></i> mutants. UBE2O recognized ribosomal proteins and other substrates directly, targeting them to proteasomes for degradation. Thus, in reticulocytes, the induction of ubiquitinating factors may drive the transition from a complex to a simple proteome.
Medical subject headings
- Erythroid Cells
- Erythropoiesis
- Ribosomal Proteins
- Ubiquitin-Conjugating Enzymes
- Ubiquitination